Pinkeye Detailer - Newport Laboratories

A NEW ERA OF VACCINE TECHNOLOGY
pinkeye
MORAXELLA BOVIS | MORAXELLA BOVOCULI
BENEFITS OF CUSTOM MADE VACCINES:
• Utilize multiple isolates to develop a unique combination product
• Potential for significant cost savings on vaccine & labor
• Keep preventative health program up to date using most current isolates
• Mirror the real-world disease challenge by using specific disease strains
• Available with DOCUVAC® vaccination compliance tool
• Easy handling, excellent syringeability
• Available in SOLIDOSE dual-dose implantable format
• Approved for 21 day pre-slaughter withdrawal
Newport Laboratories utilizes cutting-edge PINPOINT Technologies to create
Custom Made Vaccines targeting your specific needs. From the latest in
isolate analysis and selection techniques to proprietary manufacturing and
adjuvanting systems, our Custom Made Vaccines are the epitome of
science-based vaccine technology.
Call Newport Laboratories today and put
Custom Made Vaccines to work for you.
800-220-2522 | www.newportlabs.com
Custom Made Vaccines are sold exclusively through veterinarians.
ISO 9001:2008 Certified
1520 Prairie Drive | Worthington, MN 56187
800-220-2522 | f 507-372-2565
[email protected] | www.newportlabs.com
References:
1. Snowder GD, Van Vleck LD, Cundiff LV and Bennett DL. Genetic environmental factors associated with incidence of infectious bovine keratoconjunctivitis in preweaned beef calves.
J. Anim. Sci. 2005. 83:507-518.
®The Newport Laboratories Logo, DOCUVAC and PINPOINT are registered trademarks and SMFACS is a service mark of Newport Laboratories, Inc.
All other marks belong to their respective owners. ©2013 Newport Laboratories, Inc., Worthington, MN. All rights reserved. NL4801 (10/13)
MORAXELLA BOVIS | MORAXELLA BOVOCULI
pinkeye
A NEW ERA OF VACCINE TECHNOLOGY
CUSTOM MADE VACCINES:
Pinkeye (infectious bovine keratoconjunctivitis) associated with Moraxella bovis and
Custom Made Vaccines are manufactured using the specific disease causing
Moraxella bovoculi is a major factor affecting cattle health and performance. Calves
organism(s) circulating in your herd or the immediate area. Newport Laboratories
suffering from pinkeye weigh an average of 19.6 lbs less than healthy calves at
utilizes cutting-edge PINPOINT® diagnostic and production technologies to
weaning.1 Pinkeye associated with M. bovoculi is becoming a year-round problem.
create a pinkeye vaccine targeting your specific needs.
Pinkeye costs producers an estimated $150 million every year due to decreased
Newport Laboratories’ traditional and molecular diagnostics help to identify
weight gain, decreased milk production, and treatment costs. Additionally, affected
and genetically analyze the organisms that are causing disease in your herd(s).
animals are often heavily discounted by buyers.
Our Food Animal Care Specialists (FACSSM) will then help you determine which
isolate(s) to include in your Custom Made Vaccine.
STRAIN VARIATION:
Strain variation is an ongoing challenge when vaccinating for pinkeye with a
SAFETY PROTOCOLS:
commercial product.
Newport Laboratories’ Custom Made Vaccines are manufactured following USDA
approved production outlines. All of our Custom Made Vaccines are subject to
•Commercial Mor. bovis products only contain specific strains that may or
strict safety and sterility testing as required by the USDA in the
9CFR (Code of Federal Regulations).
may not be the same strains your cattle are facing.
•Commercial products do not contain M. bovoculi.
DELIVERY FORMATS:
These two factors make pinkeye a perfect candidate for a Custom Made Vaccine.
BVC RTX 12-1923-5
booster dose to be administered to the animal at the same time. The booster
BVC RTX 10-1249-4
BVC RTX 10-2774-1
Moraxella bovoculi
Gene Sequencing Shows Strain Variation
at the C-Terminus of RTX Toxin
BVC RTX 11-2274-2
Analysis performed by Newport Laboratories. Data on file.
BVC RTX 11-2274-3
BVC RTX 11-2674-3
BVC RTX 12-1923-1
BVC RTX 10-2774-3
Moraxella bovoculi reference
BVC RTX 10-1249-3
BVC RTX 10-2774-2
BVS RTX 10-2774-4
BVS RTX 11-2674-4
BVS RTX 12-1923-2
Moraxella bovis reference
BVS RTX 11-2274-1
BVS RTX 11-2274-4
14.5
14
12
10
8
6
4
Nucleotide Substitution per 100 residues
2
0
dose is programmed to release antigen for up to 2-3 weeks after administration.
NON-ADJACENT HERD USE:
Custom Made Vaccines can be used at multiple production sites and with
multiple clients through USDA Non-Adjacent Herd Use approval. This allows
BVC RTX 10-1249-2
BVS RTX 11-2674-2
Custom Made Vaccines are available as traditional liquid doses or in the
SOLIDOSE® dual-dose implantable format. SOLIDOSE allows the initial dose and
BVC RTX 11-2674-1
veterinarians greater flexibility with their Custom Made Vaccine. Newport
Moraxella bovis
A NEW ERA OF VACCINE TECHNOLOGY
pinkeye
MORAXELLA BOVIS | MORAXELLA BOVOCULI
DISEASE IMPACT:
Laboratories will assist in this process and file the appropriate forms with state
veterinarians for approval.
CUSTOM MADE VACCINES:
Pinkeye (infectious bovine keratoconjunctivitis) associated with Moraxella bovis and
Custom Made Vaccines are manufactured using the specific disease causing
Moraxella bovoculi is a major factor affecting cattle health and performance. Calves
organism(s) circulating in your herd or the immediate area. Newport Laboratories
suffering from pinkeye weigh an average of 19.6 lbs less than healthy calves at
utilizes cutting-edge PINPOINT® diagnostic and production technologies to
weaning.1 Pinkeye associated with M. bovoculi is becoming a year-round problem.
create a pinkeye vaccine targeting your specific needs.
Pinkeye costs producers an estimated $150 million every year due to decreased
Newport Laboratories’ traditional and molecular diagnostics help to identify
weight gain, decreased milk production, and treatment costs. Additionally, affected
and genetically analyze the organisms that are causing disease in your herd(s).
animals are often heavily discounted by buyers.
Our Food Animal Care Specialists (FACSSM) will then help you determine which
isolate(s) to include in your Custom Made Vaccine.
STRAIN VARIATION:
Strain variation is an ongoing challenge when vaccinating for pinkeye with a
SAFETY PROTOCOLS:
commercial product.
Newport Laboratories’ Custom Made Vaccines are manufactured following USDA
approved production outlines. All of our Custom Made Vaccines are subject to
•Commercial Mor. bovis products only contain specific strains that may or
strict safety and sterility testing as required by the USDA in the
9CFR (Code of Federal Regulations).
may not be the same strains your cattle are facing.
•Commercial products do not contain M. bovoculi.
DELIVERY FORMATS:
These two factors make pinkeye a perfect candidate for a Custom Made Vaccine.
BVC RTX 12-1923-5
booster dose to be administered to the animal at the same time. The booster
BVC RTX 10-1249-4
BVC RTX 10-2774-1
Moraxella bovoculi
Gene Sequencing Shows Strain Variation
at the C-Terminus of RTX Toxin
BVC RTX 11-2274-2
Analysis performed by Newport Laboratories. Data on file.
BVC RTX 11-2274-3
BVC RTX 11-2674-3
BVC RTX 12-1923-1
BVC RTX 10-2774-3
Moraxella bovoculi reference
BVC RTX 10-1249-3
BVC RTX 10-2774-2
BVS RTX 10-2774-4
BVS RTX 11-2674-4
BVS RTX 12-1923-2
Moraxella bovis reference
BVS RTX 11-2274-1
BVS RTX 11-2274-4
14.5
14
12
10
8
6
4
Nucleotide Substitution per 100 residues
2
0
dose is programmed to release antigen for up to 2-3 weeks after administration.
NON-ADJACENT HERD USE:
Custom Made Vaccines can be used at multiple production sites and with
multiple clients through USDA Non-Adjacent Herd Use approval. This allows
BVC RTX 10-1249-2
BVS RTX 11-2674-2
Custom Made Vaccines are available as traditional liquid doses or in the
SOLIDOSE® dual-dose implantable format. SOLIDOSE allows the initial dose and
BVC RTX 11-2674-1
veterinarians greater flexibility with their Custom Made Vaccine. Newport
Moraxella bovis
A NEW ERA OF VACCINE TECHNOLOGY
pinkeye
MORAXELLA BOVIS | MORAXELLA BOVOCULI
DISEASE IMPACT:
Laboratories will assist in this process and file the appropriate forms with state
veterinarians for approval.
A NEW ERA OF VACCINE TECHNOLOGY
pinkeye
MORAXELLA BOVIS | MORAXELLA BOVOCULI
BENEFITS OF CUSTOM MADE VACCINES:
• Utilize multiple isolates to develop a unique combination product
• Potential for significant cost savings on vaccine & labor
• Keep preventative health program up to date using most current isolates
• Mirror the real-world disease challenge by using specific disease strains
• Available with DOCUVAC® vaccination compliance tool
• Easy handling, excellent syringeability
• Available in SOLIDOSE dual-dose implantable format
• Approved for 21 day pre-slaughter withdrawal
Newport Laboratories utilizes cutting-edge PINPOINT Technologies to create
Custom Made Vaccines targeting your specific needs. From the latest in
isolate analysis and selection techniques to proprietary manufacturing and
adjuvanting systems, our Custom Made Vaccines are the epitome of
science-based vaccine technology.
Call Newport Laboratories today and put
Custom Made Vaccines to work for you.
800-220-2522 | www.newportlabs.com
Custom Made Vaccines are sold exclusively through veterinarians.
ISO 9001:2008 Certified
1520 Prairie Drive | Worthington, MN 56187
800-220-2522 | f 507-372-2565
[email protected] | www.newportlabs.com
References:
1. Snowder GD, Van Vleck LD, Cundiff LV and Bennett DL. Genetic environmental factors associated with incidence of infectious bovine keratoconjunctivitis in preweaned beef calves.
J. Anim. Sci. 2005. 83:507-518.
®The Newport Laboratories Logo, DOCUVAC and PINPOINT are registered trademarks and SMFACS is a service mark of Newport Laboratories, Inc.
All other marks belong to their respective owners. ©2013 Newport Laboratories, Inc., Worthington, MN. All rights reserved. NL4801 (10/13)
MORAXELLA BOVIS | MORAXELLA BOVOCULI
pinkeye
A NEW ERA OF VACCINE TECHNOLOGY

Download Report